symptoms of semaglutide injections Injection Sites: Best Locations & Doctor Advice Semaglutide vs Tirzepatide, which is

This article was submitted to Predictive Toxicology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Pipeline Activity The pipeline for GLP-1 and related metabolic disease treatments is extremely active

Temperature Fluctuations: Your fridge isn't a uniformly cold box

Researchers looked at 37.1 million adults with type 2 diabetes across this dataset and found a modest increase in the risk of NAION among individuals with [type 2 diabetes] associated with semaglutide use. A study published in June 2025 also connected GLP-1 RAs to neovascular age-related macular degeneration (nAMD)